BUFFALO, N.Y. — BUFFALO, N.Y. — Dr Bianca Weinstock Guttman today announced her role as Pricinpal Investigator in the MMJ clinical trials for multiple sclerosis.
MMJ’s goal is to develop and implement botanical natural pharmaceutical solutions for patients dealing with chronic illnesses by using genetic technology. From the latest research and development technologies, we offer medically proven pharmaceutical products that not only improve your health, but make lives better. We are intent on delivering medical marijuana- based medicines that give patients fuller, happier and healthier lives.
Likes: 0
Viewed: 19
source